SII to Apply for DCGI Approval for Covovax Trial on Children; Vaccine has Great Potential to Save Future Generation, Says CEO

By
-
0
289

Covovax is the second Covid-19 vaccine candidate, which is being developed and manufactured at Pune-based SII.